House of Commons - Access to clinical trial information and the stockpiling of Tamiflu - Public Accounts Committee

Public Accounts Committee - Thirty-Fifth Report
Access to clinical trial information and the stockpiling of Tamiflu

Here you can browse the report which was ordered by the House of Commons to be printed 18 December 2013.

Contents

Terms of Reference

Conclusions and recommendations

1 The availability of clinical trial results and the sharing of information between the MHRA and NICE

2 Stockpiling Tamiflu and the management of the stockpile

List of printed written evidence

List of Reports from the Committee during the current Parliament

Oral and written evidence

Monday 17 June 2013: Dr Ben Goldacre, Wellcome Research Fellow in Epidemiology, and Dr Fiona Godlee, Editor in Chief, British Medical Journal; Una O’Brien, Permanent Secretary, Department of Health, Sir Andrew Dillon, Chief Executive, National Institute for Health and Care Excellence, Professor Sir Kent Woods, Chief Executive, Medicines and Healthcare Products Regulatory Agency, and Professor Dame Sally Davies, Chief Medical officer, Department of Health

Written evidence

© Parliamentary copyright 2013
Prepared 3 January 2013